Christopher Hatwell
Physician Assistant · Marco Island, FLNPI 1164773610
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.2% of the total across 236 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 16 manufacturers reported payments, led by AbbVie at 29.8% of the total. Reporting peaked in 2021 at $1,491 and has fallen 98.4% since, to $23 in 2025.
Across 236 payments — averaging $15.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Biohaven Pharmaceuticals, Inc.$643
- Teva Pharmaceuticals USA, Inc.$611
- Biohaven Pharmaceutical Holding Company Ltd.$404
- Scilex Pharmaceuticals Inc.$246
- Pfizer$215
- plus $505 from 10 others
What the payments were for
- Food & beverage$3,70699%
- Education$311%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 62 | $1,112 |
| Biohaven Pharmaceuticals, Inc. | 46 | $643 |
| Teva Pharmaceuticals USA, Inc. | 51 | $611 |
| Biohaven Pharmaceutical Holding Company Ltd. | 29 | $404 |
| Scilex Pharmaceuticals Inc. | 12 | $246 |
| Pfizer | 11 | $215 |
| Lilly USA, LLC | 8 | $129 |
| Acadia Pharmaceuticals Inc | 6 | $124 |
| Amgen | 3 | $56 |
| Eisai Inc. | 1 | $49 |
| Upsher-smith Laboratories LLC | 2 | $33 |
| Kyowa Kirin, Inc. | 1 | $27 |
| Neurocrine Biosciences, Inc. | 1 | $26 |
| Optinose US, Inc. | 1 | $23 |
| Genentech USA, Inc. | 1 | $21 |
| Novartis | 1 | $19 |
How this compares
$3,736 in reported general payments places this provider in the 85th percentile of 8,062 physician assistant providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Memantine Hcl | 35 | $1,753 |
| Azelastine Hcl | 35 | $1,301 |
| Duloxetine Hcl | 38 | $1,170 |
| Fluticasone Propionate | 72 | $1,123 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 37 | $1,086 |
| Fluocinolone Acetonide Oil | 26 | $1,020 |
| Ipratropium Bromide | 31 | $780 |
| Ofloxacin | 24 | $724 |
| Methylprednisolone | 79 | $534 |
| Gabapentin | 31 | $398 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 31 | $373 |
| Carbidopa-Levodopa ErCarbidopa/Levodopa | 15 | $287 |
| Clonazepam | 43 | $194 |
| Mupirocin | 33 | $193 |
| Doxycycline Hyclate | 16 | $181 |
Paid to pharmacies, not to this prescriber.
Other physician assistant in Marco Island
- Audrey BeckerSt Augustine$689K
- Kevin WilliamsTampa$647K
- Brian BonomoLecanto$559K
- Melissa SingletonOcala$482K
- Reeli ReinuMaitland$427K
- Jeanelle KingMiami$424K
- Risha BellomoOrlando$397K
- Jason BergerClearwater$344K
- Ashley MillerGainesville$328K
- Nicole HillOrlando$319K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.